Jerel A. Banks - Dec 9, 2024 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Chief Executive Officer, Director
Signature
/s/ Jerel A. Banks
Stock symbol
BNTC
Transactions as of
Dec 9, 2024
Transactions value $
$0
Form type
4
Date filed
12/11/2024, 05:19 PM
Previous filing
Mar 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNTC Options (right to buy) Award $0 +2.31M $0.00 2.31M Dec 9, 2024 Common Stock 2.31M $12.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2025.